The great increase in genetical research and the marked desire of many geneticists to link their studies with other aspects of biology is, however, leading to renewed interest in the taxonomic and ...

Amgen yesterday revealed that Tepezza (teprotumumab [genetical recombination]) has been approved for the treatment of active ...

Japan’s MHLF approves Padcev with Keytruda for first-line treatment of radically unresectable urothelial carcinoma: Tokyo Wednesday, September 25, 2024, 11:00 Hrs [IST] Astellas ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the ...

In a news packed morning, Japanese drugmaker Astellas Pharma (TYO: 4503) today revealed two regulatory approvals.

Without labelling requirements for food made from a new class of 'GMO-lite' crops, consumers will be deprived of choice and ...

Amgen announced that Tepezza (teprotumumab [Genetical Recombination]) was approved by Japan's Ministry of Health, Labour and Welfare to treat active thyroid eye disease (TED) or TED with a high ...

All he required was a bit of space ahead of himself outside the penalty area to unleash the rocket that he can generate from his feet. A genetical freak in the way his body has been built, with ...

The benign tremor is genetical and runs through families. *If he finds this tremor is affecting his life enormously he should maybe try alcohol before he begins a major speech and if this doesn't ...

Nine Entertainment’s Olympic torch-bearing CEO Mike Sneesby is not the only ASX corporate chieftain to hand over the baton ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high ...